Best Life Sciences Tech Companies in Israel
The 74 best Life Sciences Tech companies in Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Aspect Imaging.
- EVERSANA
- LifeSciencesIntelligence
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Israel
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Aspect Imaging Provider of MRI and NMR systems for medical and preclinical imaging solutions | $150M | 110 mo ago | Series C | Uri Rapport Founder & CEO | 2007 | WordPressMySQLSalesforce+20 | 426 patents Advanced MRI hardware and sparse‑sampling reconstruction for brain and susceptibility imaging. | — |
| 2 | CytoReason Discovering immune system based drugs by biological data analytics 62Funding top 25%Product top 25%Innovation top 34%Growth top 35% All 11 signals ▾Fundingtop 25% Producttop 25% Innovationtop 34% Growthtop 35% Talenttop 38% Partnerstop 41% Markettop 47% Moatbottom 48% Techbottom 40% Globalbottom 36% Newsbottom 18% Funding: Raised $130M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) Product: 6 distinct product lines · Company stage: Series C rank vs industry peers · Fliar Intelligence Index 62/100 | $130M | 23 mo ago | Series C | David Harel Co-Founder and CEO | 2016 | WordPressApple iCloud MailMicrosoft 365+21 | — | 2 partnerships |
| 3 | MDClone Provider of software that creates synthetic medical records for fictitious patients | $104M | 51 mo ago | Series C | Peter Schon CFO & COO | 2016 | WordPressApple iCloud MailGoogle Workspace+16 | 18 patents Synthetic health data generation and longitudinal patient data management platforms | 1 launch · 2 partnerships |
| 4 | Quris Ai AI-based drug candidate predicting tool for healthcare professionals | $37M | 42 mo ago | Seed | Isaac Bentwich Co-Founder & CEO | 2020 | Wix eCommerceWixSentry+15 | — | — |
| 5 | BeaconCure Developer of an AI-enabled statistical analysis platform for biometrics teams 16Moat top 41%Funding top 46%Talent bottom 49%Market bottom 43% All 9 signals ▾Moattop 41% Fundingtop 46% Talentbottom 49% Marketbottom 43% Techbottom 38% Patentsbottom 35% Globalbottom 29% Newsbottom 22% Innovationbottom 21% Moat: Editorial + unicorn rating 7/10 · IP moat: 2 patents Funding: Raised $25.9M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 16/100 | $26M | 17 mo ago | Series C | Ilan Carmeli COO & Co-Founder | 2016 | — | 2 patents Automated validation of tabular data reports for compliance and error detection | 1 launch |
| 6 | QuantHealth Provider of AI-based clinical trail management tool for researchers 55AI top 30%Funding top 34%Growth top 35%Moat top 39% All 9 signals ▾AItop 30% Fundingtop 34% Growthtop 35% Moattop 39% Techtop 42% Talentbottom 49% Newsbottom 42% Globalbottom 38% Marketbottom 32% AI: Classified as an AI company · Product described with: ai-based Funding: Raised $22.0M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 55/100 | $22M | 8 mo ago | Series A | Orr Inbar Co-Founder & CEO | 2020 | DatoCMSApple iCloud MailGoogle Workspace+20 | — | 1 award |
| 7 | Protai Provider of AI-enabled platform for proteomics based drug discovery and development | $20M | 39 mo ago | Seed | — | 2021 | WebflowReactcore-js+13 | — | 1 award |
| 8 | Mana.bio AI-based drug delivery technology for research and development | $20M | 32 mo ago | Seed | Yogev Debbi Co-Founder & CEO | 2021 | WixSentryBootstrap+11 | — | 2 partnerships |
| 9 | Geneyx Provider of a clinical genetics data management platform for hospitals and genetic labs | $10M | 55 mo ago | Seed | — | 2018 | WordPressBetterDocsMySQL+37 | — | — |
| 10 | Promise Provider of AI-based platform for personalised treatment plans 62Talent top 28%AI top 45%Global top 45%Funding top 47% All 6 signals ▾Talenttop 28% AItop 45% Globaltop 45% Fundingtop 47% Moattop 48% Marketbottom 49% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 62/100 | $8M | 18 mo ago | Seed | Ronel Veksler Co-Founder & CEO | 2020 | — | — | — |
| 11 | Pepticom Developer of AI-based technology for the discovery of peptide drug candidates 35Moat top 31%Growth top 35%Product top 36%AI top 45% All 10 signals ▾Moattop 31% Growthtop 35% Producttop 36% AItop 45% Techbottom 46% Patentsbottom 45% Fundingbottom 40% Globalbottom 40% Innovationbottom 37% Marketbottom 29% Moat: Editorial + unicorn rating 7/10 · IP moat: 15 patents Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 35/100 | $8M | 17 mo ago | Series A | — | 2011 | WordPressMySQLPHP+20 | 15 patents Therapeutic peptides and small‑molecule modulators for immune receptors, GABAA, and antimicrobial pathways | — |
| 12 | Genome Compiler Corporation Provider of DNA design & visualization, data management and collaboration | $5M | 152 mo ago | Acqui-Hired | Omri Amirav-Drory Founder & CEO | 2011 | — | 2 patents Software platform for designing, visualizing, and ordering synthetic DNA constructs | — |
| 13 | BioRaptor AI-powered insight platform to detect abnormalities in drug discovery | $3M | 26 mo ago | Seed | — | 2021 | — | — | — |
| 14 | Algocell Provider of AI-powered bioprocess optimization solutions 27Talent top 38%AI top 45%Tech top 49%Funding bottom 42% All 6 signals ▾Talenttop 38% AItop 45% Techtop 49% Fundingbottom 42% Globalbottom 32% Marketbottom 25% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated AI: Product described with: ai-powered rank vs industry peers · Fliar Intelligence Index 27/100 | $3M | 11 mo ago | Seed | Omri Schanin Co-Founder & CEO | 2023 | WordPressMySQLPHP+21 | — | — |
| 15 | STARLIMS Technologies Digital LIMS for reserach labaratory | — | 5 mo ago | Acquired | Trey Cook President and Chief Executive Officer | 1987 | — | 2 patents Graphical software tools for creating device connectivity drivers (software integration) | — |
Top 12 Life Sciences Tech companies in Israel
#1
Series A · Tel Aviv, Tel Aviv · founded 2020 · 21 employees$22Mraised▾
Provider of AI-based clinical trail management tool for researchers. It allow users to evaluate each parameter independently, or discover the optimal protocol that maximizes efficacy and safety.
- Oct 2025Series A—
- Jan 2024Series A$2M
- Aug 2023Series A$15M
- Oct 2022Seed$2.6M
#2
Series C · Haifa, Haifa District · founded 2016 · 133 employees$130Mraised▾
Discovering immune system-based drugs by biological data analytics. It is using its proprietary platform of scientific and experimental data to stimulate the immune system so as to analyze its exponential growth in high-resolution patient data and in scientific research.
- Jul 2024Conventional Debt—
- Jul 2024Series C$80M
- Sep 2022Series B$20M
#3
Series C · Tel Aviv, Tel Aviv · founded 2016 · 27 employees$25.9Mraised▾
Developer of an AI-enabled statistical analysis platform for biometrics teams. The platform unifies review roles within a fit-for-purpose environment. It enhances visible collaboration, accountability, and efficiency. The AI algorithms are refined through metadata extraction and expert feedback. The platform delivers validation, data transformation, and metadata reuse. An automated activity log maintains a real-time audit trail.
- Jan 2025Series C$15M
- Jun 2023Series B$14M
- Mar 2023Series A$9.9M
- Nov 2021Seed$2M
#4
Seed · Rehovot, Central District · founded 2023$2.8Mraised▾
Provider of AI-powered bioprocess optimization solutions. It uses hybrid models, digital twins, and advanced AI technologies to accelerate bioprocess development and scale-up. The platform allows users to upload data, calibrate models, and create digital twins for gaining insights into cell line metabolism, optimizing protocols, and ensuring seamless transitions from pilot to manufacturing. This approach reduces trial-and-error experimentation, improves cell productivity, and enables real-time optimization during production. Key technologies include engineering models, data intelligence, design of experiments, AI optimization algorithms, and hybrid biological models.
- Jul 2025Seed$2.8M
- Jul 2025Grant (prize money)—
#5
Series A · Jerusalem, Jerusalem District · founded 2011 · 18 employees$7.6Mraised▾
Developer of AI-based technology for the discovery of peptide drug candidates. The platform's technology is an algorithm that assists in protein-protein interface and peptide-protein interface enabling the design of binding peptides, agonists, and antagonists that are intended to block protein-protein interactions. It analyzes the target surface surrounding the desired binding area and then performs a design process to provide a peptide library with optimal binding affinity.
- Jan 2025Series A$6.6M
- Mar 2021Series A$2.6M
- Oct 2019Series A$5M
- Aug 2013Seed—
#6
Seed · Tel Aviv, Tel Aviv · founded 2020$8.3Mraised▾
Provider of AI-based platform for personalised treatment plans. It utilizes a cloud-based AI platform to perform unbiased epiproteomic analyses on standard mass-spectrometry data, optimizing personalized treatment plans and facilitating disease diagnosis.
- Dec 2024Grant (prize money)—
- Dec 2024Seed$8.3M
#7
Series C · Be er Sheva, South District · founded 2016 · 142 employees$104Mraised▾
MDClone designs and develops software that analyzes medical records. The MDClone engine process examines medical data, extracts their statistical characteristics and dependencies, and extrapolates from these to generate a new data set containing sham medical records for fictitious patients, thus claiming to overcome the risk of public disclosure of medical data from actual patients.
- Mar 2022Series C$63M
- Aug 2019Series B$26M
- Feb 2018Series B$15M
- 2017Seed—
#8
Seed · Tel Aviv, Tel Aviv · founded 2021 · 17 employees$19.5Mraised▾
AI-based drug delivery technology for research and development. It offers machine learning and nanotechnology platformr to identify formulations of lipid nanoparticles drug delivery systems, gene therapy including DNA and RNA-based therapeutics, and vaccines.
- Oct 2023Seed$19.5M
#9
Seed · Tel Aviv-Yafo, Tel Aviv · founded 2020 · 45 employees$37Mraised▾
AI-based drug candidate predicting tool for healthcare professionals. The company has developed software that assists with the drug development process. It has features for clinical predictive tools, clinical trial management, drug development process management, and more.
- Dec 2022Seed$9M
- Jan 2022Seed$19M
- Oct 2021Seed$9M
#10
Seed · Tel Aviv, Tel Aviv · founded 2021 · 11 employees$20Mraised▾
Provider of AI-enabled platform for proteomics based drug discovery and development
- Mar 2023Seed$12M
- Jan 2022Seed$8M
#11
Series C · Shoham, Center District · founded 2007 · 87 employees$150Mraised▾
Aspect Imaging develops solutions for medical and preclinical imaging. It has three main business units. The Medical MRI unit has the portable WristView MRI system and a neonatal MRI system for use in the NICU that is still under development. The Preclinical MRI unit has the Aspect One-Touch MRI, LumiQuant for 3D Quantified Luminescence and the Mediso NanoScan which integrates both PET-MRand SPECT-MR systems. In addition, it also has industrial MRI solutions. It also offers the FlowScan platform which is online and quantitative information for processing for rheology applications. The company product WristView is FDA-cleared.
- Apr 2017Series C$30M
- Jul 2016Series B$20M
#12
Seed · Binyamina Giv at Ada, Haifa District · founded 2021 · 9 employees$3Mraised▾
AI-powered insight platform to detect abnormalities in drug discovery. The platform empowers scientist and biotech firm, making AI-powered insights and to discover, develop and scale processes from alt-protein foods to new biopharmaceuticals.
- Apr 2024Seed—
- Oct 2022Seed$3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Israel
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 267 Israel-affiliated papers.
- Ministry of Agriculture118
- Hebrew University of Jerusalem29
- Agricultural Research Organization25
- Tel Aviv University21
- Ben-Gurion University of the Negev19
- Mitochondrion1→5
- Gene1→18
- Plant disease resistance1→7
- Resistance (ecology)2→6
- Agriculture3→6
Where biotechnology is researched across Israel
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.